| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |